CHICAGO (GenomeWeb) – Results presented at the American Society of Clinical Oncology annual meeting here this week are highlighting the possibility of using immune checkpoint inhibitors as a first-line therapy in advanced or metastatic non-small cell lung cancer (NSCLC), though the molecular features marking the cases that may benefit most from immunotherapy alone or in combination with chemotherapy are still being hammered out.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.